Consolidating balance sheet foreign currency

Posted by / 27-May-2020 06:14

Consolidating balance sheet foreign currency

Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC and we do not undertake to update any forward-looking statement.In addition, the reconciliations of any non-GAAP financial measures are available on our website, investorrelations.Finally, other than as noted, our EPS growth and guidance does not include any charges or gains that would be recorded as non-GAAP adjustments to earnings during the fiscal year.

As we look ahead, we are confident in our ability to deliver a meaningful EPS leverage on mid-single digit revenue growth this fiscal year just as we have for the past five fiscal years.

Q3 non-GAAP operating profit grew 8% and non-GAAP diluted earnings per share were a

As we look ahead, we are confident in our ability to deliver a meaningful EPS leverage on mid-single digit revenue growth this fiscal year just as we have for the past five fiscal years.

Q3 non-GAAP operating profit grew 8% and non-GAAP diluted earnings per share were a $1.17 growing 12% and representing EPS leverage of 580 basis points.

These results reflect a solid quarter for Medtronic, and as we expected, a strong turnaround from the first half of the fiscal year.

In brain, the strength of our entire stroke portfolio drove high-teens growth in neurovascular and strong sales of our Stealth Station navigation and O-arm imaging technologies led to low double-digit growth in neurosurgery.

In pain, we're seeing very positive customer reaction from our Intellis platform and our evolved work for algorithm, which together drove high single-digit growth, reversing the declines we've seen for several quarters.

||

As we look ahead, we are confident in our ability to deliver a meaningful EPS leverage on mid-single digit revenue growth this fiscal year just as we have for the past five fiscal years.Q3 non-GAAP operating profit grew 8% and non-GAAP diluted earnings per share were a $1.17 growing 12% and representing EPS leverage of 580 basis points.These results reflect a solid quarter for Medtronic, and as we expected, a strong turnaround from the first half of the fiscal year.In brain, the strength of our entire stroke portfolio drove high-teens growth in neurovascular and strong sales of our Stealth Station navigation and O-arm imaging technologies led to low double-digit growth in neurosurgery.In pain, we're seeing very positive customer reaction from our Intellis platform and our evolved work for algorithm, which together drove high single-digit growth, reversing the declines we've seen for several quarters.

.17 growing 12% and representing EPS leverage of 580 basis points.

These results reflect a solid quarter for Medtronic, and as we expected, a strong turnaround from the first half of the fiscal year.

In brain, the strength of our entire stroke portfolio drove high-teens growth in neurovascular and strong sales of our Stealth Station navigation and O-arm imaging technologies led to low double-digit growth in neurosurgery.

In pain, we're seeing very positive customer reaction from our Intellis platform and our evolved work for algorithm, which together drove high single-digit growth, reversing the declines we've seen for several quarters.

consolidating balance sheet foreign currency-33consolidating balance sheet foreign currency-8consolidating balance sheet foreign currency-48

In TAVR, we grew in the low 30s with mid-20s growth in the US and low 40s growth in international markets driven by the strong global demand for Evolut PRO valve and expanded indications for us.

One thought on “consolidating balance sheet foreign currency”